1st Quarter - Report
SHIRE PHARMACEUTICALS LLC for SHIRE PHARMACEUTICALS LLC
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to implementation of healthcare reform; ADHD awareness; R&D funding for rare disease products, biosimilars and other products; end stage renal disease (ESRD) bundling of non-injectable oral equivalents; ESRD Quaklity Incentive program; reimbursements; Prescription Drug User Fee program; S.606, Creating Hope Act of 2011; Life Sciences Investment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOFF MASUKAWA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.